Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The therapeutic and prognostic role of clusterin in diverse musculoskeletal diseases: a mini review

K. Zhang, K. Liu, D. Yu, Y. Tang, B. Geng, Y. Xia, P. Xu

. 2022 ; 71 (6) : 739-747. [pub] 20221013

Jazyk angličtina Země Česko

Typ dokumentu přehledy, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22029569

This mini-review aims to introduce the association between Secretory clusterin/apolipoprotein J (sCLU) and diverse musculoskeletal diseases. A comprehensive review of the literature was performed to identify basic science and clinical studies, which implied the therapeutic and prognostic role of sCLU in diverse musculoskeletal diseases. sCLU is a multifunctional glycoprotein that is ubiquitously expressed in various tissues and is implicated in many pathophysiological processes. Dysregulated expression of sCLU had been reported to be assocaited with proliferative or apoptotic molecular processes and inflammatory responses, which participated in many pathophysiological processes such as degenerative musculoskeletal diseases including ischemic osteonecrosis, osteoarthritis (OA) and degenerative cervical myelopathy (spinal cord injury), neoplastic musculoskeletal diseases, inflammatory and autoimmune musculoskeletal diseases including Rheumatoid arthritis (RA), joint damage induced by Brucella abortus, Sjogren's syndrome, idiopathic inflammatory myopathies, muscle glucose metabolism, insulin sensitivity and traumatic musculoskeletal diseases. Recent findings of sCLU in these musculoskeletal diseases provides insights on the therapeutic and prognostic role of sCLU in these musculoskeletal diseases. sCLU may serve as a promising therapeutic target for ischemic osteonecrosis, OA and spinal cord injury as well as a potential prognostic biomarker for OA and RA. Moreover, sCLU could act as a prognostic biomarker for osteosarcoma (OS) and a promising therapeutic target for OS resistance. Although many studies support the potential therapeutic and prognostic role of sCLU in some inflammatory and autoimmune-mediated musculoskeletal diseases, more future researches are needed to explore the molecular pathogenic mechanism mediated by sCLU implied in these musculoskeletal diseases.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22029569
003      
CZ-PrNML
005      
20230519085258.0
007      
ta
008      
230113s2022 xr f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934908 $2 doi
035    __
$a (PubMed)36281729
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Zhang, Kung $u Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
245    14
$a The therapeutic and prognostic role of clusterin in diverse musculoskeletal diseases: a mini review / $c K. Zhang, K. Liu, D. Yu, Y. Tang, B. Geng, Y. Xia, P. Xu
520    9_
$a This mini-review aims to introduce the association between Secretory clusterin/apolipoprotein J (sCLU) and diverse musculoskeletal diseases. A comprehensive review of the literature was performed to identify basic science and clinical studies, which implied the therapeutic and prognostic role of sCLU in diverse musculoskeletal diseases. sCLU is a multifunctional glycoprotein that is ubiquitously expressed in various tissues and is implicated in many pathophysiological processes. Dysregulated expression of sCLU had been reported to be assocaited with proliferative or apoptotic molecular processes and inflammatory responses, which participated in many pathophysiological processes such as degenerative musculoskeletal diseases including ischemic osteonecrosis, osteoarthritis (OA) and degenerative cervical myelopathy (spinal cord injury), neoplastic musculoskeletal diseases, inflammatory and autoimmune musculoskeletal diseases including Rheumatoid arthritis (RA), joint damage induced by Brucella abortus, Sjogren's syndrome, idiopathic inflammatory myopathies, muscle glucose metabolism, insulin sensitivity and traumatic musculoskeletal diseases. Recent findings of sCLU in these musculoskeletal diseases provides insights on the therapeutic and prognostic role of sCLU in these musculoskeletal diseases. sCLU may serve as a promising therapeutic target for ischemic osteonecrosis, OA and spinal cord injury as well as a potential prognostic biomarker for OA and RA. Moreover, sCLU could act as a prognostic biomarker for osteosarcoma (OS) and a promising therapeutic target for OS resistance. Although many studies support the potential therapeutic and prognostic role of sCLU in some inflammatory and autoimmune-mediated musculoskeletal diseases, more future researches are needed to explore the molecular pathogenic mechanism mediated by sCLU implied in these musculoskeletal diseases.
650    _2
$a lidé $7 D006801
650    _2
$a klusterin $x metabolismus $7 D051152
650    _2
$a prognóza $7 D011379
650    _2
$a biologické markery $x metabolismus $7 D015415
650    12
$a muskuloskeletální nemoci $x diagnóza $x terapie $7 D009140
650    12
$a osteonekróza $7 D010020
650    12
$a poranění míchy $7 D013119
650    _2
$a nádorové buněčné linie $7 D045744
655    _2
$a přehledy $7 D016454
655    _2
$a časopisecké články $7 D016428
700    1_
$a Liu, Kaixin $u Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
700    1_
$a Yu, Dechen $u Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an, China
700    1_
$a Tang, Yuchen $u Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, China
700    1_
$a Geng, Bin $u Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, China
700    1_
$a Xia, Yayi $u Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, China
700    1_
$a Xu, Peng $u Department of Joint Surgery, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 71, č. 6 (2022), s. 739-747
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36281729 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20230113 $b ABA008
991    __
$a 20230519085251 $b ABA008
999    __
$a ok $b bmc $g 1894764 $s 1180894
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 71 $c 6 $d 739-747 $e 20221013 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK198 $a Pubmed-20230113

Najít záznam

Citační ukazatele

Možnosti archivace